Dexcom will stop producing G6 CGM sensors July 1, 2026, urging patients to switch to the smaller, more accurate G7 model.

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. DexCom (NasdaqGS:DXCM) announced new AI-enabled features ...

DexCom, Inc. (DXCM) 47th Annual Raymond James Institutional Investor Conference March 2, 2026 1:05 PM ESTCompany ParticipantsJereme Sylvain - Executive ...

Earnings call Dexcom delivered Q4 2025 revenue of $1.26B (+13% YoY), exceeding guidance, with gross margin expanding 410 bps YoY to 63.5%. FY25 free cash flow surpassed $1B. For FY26, guidance calls ...

The Helsinki‑based company offers AI-enabled biometric and gesture recognition technology that allows for device control with natural movements.

Theranica, a neuromodulation therapeutics company advancing clinically validated, drug-free treatments for idiopathic pain conditions and setting a new standard of care in migraine with REN-based ...

Study Confirms Safety of Using Theranica’s Nerivio REN Wearable for Treatment of Migraine Simultaneously with Contemporary Continuous Glucose Monitoring (CGM) Devices Published in the Journal of ...

St. John Neumann's Buckley, diagnosed with Type 1 diabetes at 8, navigates the daily challenges of managing his condition while excelling on the mat.

Dublin , Ireland - 28 December 2024; Erin King of Wolfhounds after her side's defeat in the Celtic Challenge match between Clovers and Wolfhounds at the UCD Bowl in Dublin. (Photo By Piaras ...

Verizon is leveraging connectivity and devices to decentralize healthcare, enabling remote monitoring and telemedicine, ...

In the preceding three months, 12 analysts have released ratings for DexCom (NASDAQ:DXCM), presenting a wide array of ...

One underappreciated reason why I feel DXCM could potentially gain more favorable interest is because its long-suffering ...